What is Guardant?
Guardant Health, established in 2012 and headquartered in Palo Alto, California, specializes in providing advanced cancer diagnostics and classification services. The company's core offerings include rare-cell diagnostics and comprehensive testing reports designed to empower physicians with critical information for identifying optimal treatment strategies for cancer patients. By leveraging cutting-edge technology, Guardant Health aims to revolutionize cancer care through early detection and personalized treatment approaches, thereby improving patient outcomes and driving innovation in oncology.
How much funding has Guardant raised?
Guardant has raised a total of $1.2B across 8 funding rounds:
Series A
$10M
Series B
$30M
Series C
$50M
Series D
$100M
Series E
$360M
Stock Offering
$273.1M
Stock Offering
$319.5M
Share Placement
$100M
Series A (2014): $10M with participation from Frank Malek, Steamboat Ventures, and Osage University Partners
Series B (2014): $30M led by Khosla Ventures, Pejman Mar Ventures, and Steamboat Ventures
Series C (2015): $50M supported by Lightspeed Venture Partners, Khosla Ventures, Formation8, and Steamboat Ventures
Series D (2016): $100M featuring Pejman Mar, OrbiMed, Heritage Group, Lightspeed Venture Partners, Khosla Ventures, Formation8, and Steamboat Ventures
Series E (2017): $360M backed by 8VC, OrbiMed, T. Rowe Price, Lightspeed Venture Partners, SoftBank, Khosla Ventures, Temasek, and Steamboat Ventures
Stock Issuance/Offering (2018): $273.1M, investors not publicly disclosed
Stock Issuance/Offering (2019): $319.5M, investors not publicly disclosed
Share Placement (2025): $100M, investors not publicly disclosed
Key Investors in Guardant
Lightspeed Venture Partners
Lightspeed Venture Partners (lsvp.com) is a global multistage venture capital firm that raises dedicated funds and invests in early and growthstage technology companies across sectors such as enterprise software, consumer, fintech, and infrastructure, partnering with founders from seed through IPO/M&A.
Khosla Ventures
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies. The firm was founded in 2004 by Vinod Khosla, co-founder of Sun Microsystems. With over fourteen billion dollars under management, the firm focuses on a broad range of areas including consumer, enterprise, ai, fintech and financial services, semiconductors, health, agriculture/food, sustainable energy, and robotics.
Steamboat Ventures
Steamboat Ventures, founded in 2000, focuses on helping young companies become market leaders. They invest in early to growth stage companies within the technology, media, and consumer sectors. The firm is dedicated to creating lasting value in each of its investments. Their approach emphasizes a commitment to nurturing and supporting the growth of their portfolio companies.
What's next for Guardant?
With substantial financial backing, Guardant Health is strategically positioned for continued expansion and innovation in the cancer diagnostics sector. The company's ongoing access to significant capital, including major enterprise-level funding and strategic investments, suggests a focus on scaling its operations, enhancing its diagnostic platforms, and potentially broadening its market reach. Future developments are likely to involve further advancements in liquid biopsy technology, expansion of its testing portfolio to cover a wider range of cancer types and stages, and deeper integration of its diagnostic insights into clinical decision-making pathways. The company's trajectory indicates a strong commitment to transforming cancer care through precision medicine and data-driven insights.
See full Guardant company page
